Related Experiment Video
Updated: Dec 6, 2025
08:19
Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties
Published on: May 19, 2023
2.3K
A Machine Learning-Assisted Nanoparticle-Printed Biochip for Real-Time Single Cancer Cell Analysis
Kushal Joshi1, Alireza Javani2, Joshua Park2
1Department of Biomedical Engineering, University of California Irvine, Irvine, CA, 92697, USA.
Advanced Biosystems
|October 7, 2020
Summary
This study introduces a novel machine learning-assisted biochip for single-cell analysis. The cost-effective, nanoparticle-printed device can differentiate cancerous from noncancerous cells and classify cancer subtypes, aiding tumor heterogeneity studies.
Area of Science:
- Biotechnology
- Nanotechnology
- Machine Learning
Background:
- Cancer is a complex disease characterized by cellular heterogeneity, leading to treatment resistance and varied patient outcomes.
- Single-cell analysis is crucial for understanding tumor heterogeneity and developing effective cancer therapies.
- Existing methods for single-cell analysis can be costly and complex, limiting accessibility.
Purpose of the Study:
- To develop a machine learning-assisted nanoparticle-printed biochip for cost-effective single-cell analysis.
- To demonstrate the biochip's capability in label-free differentiation of cell types, including cancerous and noncancerous cells.
- To showcase the potential for classifying cancer subtypes and aiding point-of-care diagnostics.
Main Methods:
- Integration of machine learning algorithms with inkjet printing and microfluidics technology.
- Development of a nanoparticle-printed biochip for single-cell analysis.
- Establishment and evaluation of n-feature classifiers for cell discrimination.
Main Results:
- Demonstrated label-free differentiation of various cell types at the single-cell level.
- Successfully discriminated between noncancerous and cancerous cells.
- Showcased the ability to classify cancer subtype cells, highlighting potential for tumor heterogeneity studies.
Conclusions:
- The developed biochip offers a miniaturized, cost-effective, and prototype-able platform for single-cell analysis.
- This technology has significant potential for advancing single-cell and tumor heterogeneity research.
- The biochip could be valuable for point-of-care cancer diagnostics, particularly in resource-limited settings.
